We hypothesized that the prevalence of anti-dengue IgG from previous infections might interfere with IgM or IgA seroconversion of current ZIKV infection, making the rates of positivity for IgM or IgA appear much lower than those of IgA/M combined. The gene discussed is CD79A; the disease is Zika virus infectious disease.